Polyanhydrides as localized drug delivery carrier: an update

Bibliography

• Amsden BG. Biodegradable elastomers in drug delivery. Expert Opin Drug Deliv 2008;5:175-87
   PubMed Web of Science ®Google Scholar
• Drotleff S, Lungwitz U, Breunig M, et al. Biomimetic polymers in pharmaceutical and biomedical sciences. Eur J Pharm Biopharm 2004;58:385-407
   PubMed Web of Science ®Google Scholar
• Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-43
   PubMed Web of Science ®Google Scholar
• Langer R. New methods of drug delivery. Science 1990;249:1527-33
   PubMed Web of Science ®Google Scholar
• Langer R. Drug delivery and targeting. Nature 1998;392:5-10
   PubMed Web of Science ®Google Scholar
• Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci 2007;32:762-98
   Web of Science ®Google Scholar
• Brem H. Polymers to treat brain tumours. Biomaterials 1990;11:699-701
   PubMed Web of Science ®Google Scholar
• Saltzman WM, Fung LK. Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev 1997;26:209-30
   PubMed Web of Science ®Google Scholar
• Kavanagh CA, Rochev YA, Gallagher WM, et al. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacol Ther 2004;102:1-15
   PubMed Web of Science ®Google Scholar
• Laurencin CT, Gerhart T, Witschger P, et al. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J Orthop Res 1993;11:256-62
   PubMed Web of Science ®Google Scholar
• Garvin K, Feschuk C, Schmidmaier G, et al. Polylactide–polyglycolide antibiotic implants: prophylaxis and treatment of implant-related infections by antibiotic-coated implants. Clin Orthop Relat Res 2005;437:105-10
   PubMed Web of Science ®Google Scholar
• Schmidmaier G, Lucke M, Wildemann B, et al. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 2006;37(Suppl 2):S105-12
   PubMed Web of Science ®Google Scholar
• Jampel HD, Thibault D, Leong KW, et al. Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers. Invest Ophthalmol Vis Sci 1993;34:3076-83
   PubMed Web of Science ®Google Scholar
• Dhanikula AB, Panchagnula R. Localized paclitaxel delivery. Int J Pharm 1999;183:85-100
   PubMed Web of Science ®Google Scholar
• Moses MA, Brem H, Langer R. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 2003;4:337-41
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia HM, Vaina S, Tsuchida K, et al. Drug-eluting stents. Arch Cardiol Mex 2006;76:297-319
   PubMedGoogle Scholar
• Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation 1994;90:2070-84
   PubMed Web of Science ®Google Scholar
• Wang PP, Frazier J, Brem H. Local drug delivery to the brain. Adv Drug Deliv Rev 2002;54:987-1013
   PubMed Web of Science ®Google Scholar
• Angelova N, Hunkeler D. Rationalizing the design of polymeric biomaterials. Trends Biotechnol 1999;17:409-21
   PubMed Web of Science ®Google Scholar
• Domb AJ. Polymers for site-specific drug delivery. In: Domb AJ, editor, Polymeric site-specific pharmacotherapy. Wiley, Chichester; 1994. p. 1-26
   Google Scholar
• Domb AJ, Maniar M. Absorbable biopolymers derived from dimer fatty acids. J Polym Sci A Polym Chem 1993;31:1275-85
   Web of Science ®Google Scholar
• Lee S-H, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007;59:339-59
   PubMed Web of Science ®Google Scholar
• Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007;59:207-33
   PubMed Web of Science ®Google Scholar
• Tamada JA, Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 1993;90:552-6
   PubMed Web of Science ®Google Scholar
• Gopferich A, Tessmar J. Polyanhydride degradation and erosion. Adv Drug Deliv Rev 2002;54:911-31
   PubMed Web of Science ®Google Scholar
• Dang W, Daviau T, Brem H. Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm Res 1996;13:683-91
   PubMed Web of Science ®Google Scholar
• Jain JP, Modi S, Kumar N. Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J Biomed Mater Res A 2008;84:740-52
   PubMedGoogle Scholar
• Domb AJ, Gallardo CF, Langer R. Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids. Macromolecules 1989;22:3200-4
   Web of Science ®Google Scholar
• Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002;54:889-910
   PubMed Web of Science ®Google Scholar
• Shakesheff KM, Davis MC, Domb AJ, et al. In situ atomic force microscopy visualization of the degradation of melt crystallized poly(sebacic anhydride). Macromolecules 1995;28:1108-14
   Web of Science ®Google Scholar
• Domb A. Synthesis and characterization of biodegradable aromatic anhydride copolymers. Macromolecules 1992;25:12-7
   Web of Science ®Google Scholar
• Leach KJ, Mathiowitz E. Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation. Biomaterials 1998;19:1973-80
   PubMed Web of Science ®Google Scholar
• Teomim D, Nyska A, Domb AJ. Ricinoleic acid-based biopolymers. J Biomed Mater Res 1999;45:258-67
   PubMed Web of Science ®Google Scholar
• Slivniak R, Ezra A, Domb AJ. Hydrolytic degradation and drug release of ricinoleic acid-lactic acid copolyesters. Pharm Res 2006;23:1306-12
   PubMed Web of Science ®Google Scholar
• Teomim D, Domb AJ. Fatty acid terminated polyanhydrides. J Polym Sci A Polym Chem 1999;37:3337-44
   Web of Science ®Google Scholar
• Teomim D, Domb AJ. Nonlinear fatty acid terminated polyanhydrides. Biomacromolecules 2001;2:37-44
   PubMed Web of Science ®Google Scholar
• Burkoth AK, Burdick J, Anseth KS. Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior. J Biomed Mater Res 2000;51:352-9
   PubMed Web of Science ®Google Scholar
• Roman JS, Madruga EL, Pargada L. Thermal degradation of poly(o-methacryloyloxybenzoic acid). Polym Degrad Stab 1987;19:161-76
   Web of Science ®Google Scholar
• Cheng G, Aponte MA, Ramirez CA. Synthesis and characterization of cross-linked amino acid-containing polyanhydrides for controlled drug release applications. PMSE Preprints 2003;89:618-9
   Google Scholar
• Zhang Z-Q, Su X-M, He H-P, et al. Synthesis, characterization, and degradation of poly(anhydride-co-amide)s and their blends with polylactide. J Polym SciA Polym Chem 2004;42:4311-7
   Web of Science ®Google Scholar
• Anastasiou TJ, Uhrich KE. Aminosalicylate-based biodegradable polymers: Syntheses and in vitro characterization of poly(anhydride-ester)s and poly(anhydride-amide)s. J Polym Sci A Polym Chem 2003;41:3667-79
   Web of Science ®Google Scholar
• Erdmann L, Uhrich KE. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials 2000;21:1941-6
   PubMed Web of Science ®Google Scholar
• Ben-Shabat S, Elmalak O, Nyska A, et al. Synthesis and characterization of biodegradable copolyesters and copolyanhydrides prepared from fumaric and succinic acid trimers and oligomers. Isr J Chem 2005;45:411-20
   Web of Science ®Google Scholar
• Katarzyna J. Synthesis and characterization of new functional poly(ester-anhydride)s based on succinic and sebacic acids. Macromol Symp 2007;254:109-16
   Google Scholar
• Akbari H, D'Emanuele A, Attwood D. Effect of geometry on the erosion characteristics of polyanhydride matrices. Int J Pharm 1998;160:83-9
   Google Scholar
• Mathiowitz E, Bernstein H, Giannos S, et al. Polyanhydride microspheres. IV. Morphology and characterization of system made by spray drying. J Appl Polym Sci 1992;45:125-34
   Web of Science ®Google Scholar
• Tabata Y, Langer R. Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds. Pharm Res 1993;10:391-9
   PubMed Web of Science ®Google Scholar
• Gopferich A, Karydas D, Langer R. Predicting drug release from cylindrical polyanhydride matrix discs. Eur J Pharm Biopharm 1995;41:81-7
   Web of Science ®Google Scholar
• Gopferich A, Langer R. Modeling of polymer erosion. Macromolecules 1993;26:4105-12
   Web of Science ®Google Scholar
• Gopferich A, Langer R. Modeling of polymer erosion in three dimensions: rotationally symmetric devices. AIChE J 1995;41:2292-9
   Web of Science ®Google Scholar
• Zygourakis K. Development and temporal evolution of erosion fronts in bioerodible controlled release devices. Chem Eng Sci 1990;45:2359-66
   Web of Science ®Google Scholar
• Zygourakis K, Markenscoff PA. Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach. Biomaterials 1996;17:125-35
   PubMed Web of Science ®Google Scholar
• Bucher JE, Slade WC. The anhydrides of isophthalic and terephthalic acids. J Am Chem Soc 1909;31:1319-21
   Google Scholar
• Conix A. Aromatic poly(anhydrides): a new class of high melting fiber-forming polymers. J Polym Sci A 1958;29:343-53
   Web of Science ®Google Scholar
• Hill JW, Carothers HW. Studies on polymerization and ring formation. XIV. A linear superpolyanhydride and a cyclic dimeric anhydride from sebacic acid. J Am Chem Soc 1932;54:5169
   Google Scholar
• Leong KW, Kost J, Mathiowitz E, et al. Polyanhydrides for controlled release of bioactive agents. Biomaterials 1986;7:364-71
   PubMed Web of Science ®Google Scholar
• Rosen HB, Chang J, Wnek GE, et al. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials 1983;4:131-3
   PubMed Web of Science ®Google Scholar
• Yoda N. Synthesis of poly(anhydrides). Poly(anhydrides) of five-membered heterocyclic dibasic acids. Makromol Chem 1962;55:174-90
   Google Scholar
• Kim MS, Seo KS, Seong HS, et al. Synthesis and characterization of polyanhydride for local BCNU delivery carriers. Biomed Mater Eng 2005;15:229-38
   PubMed Web of Science ®Google Scholar
• Vogel BM, Mallapragada SK. Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices. Biomaterials 2005;26:721-8
   PubMed Web of Science ®Google Scholar
• Domb AJ, Mathiowitz E, Ron E, et al. Polyanhydrides. IV. Unsaturated and crosslinked polyanhydrides. J Polym Sci A Polym Chem 1991;29:571-9
   Web of Science ®Google Scholar
• Maniar M, Domb A, Haffer A, et al. Controlled release of a local anesthetic from fatty acid dimer based polyanhydride. J Control Release 1994;30:233-9
   Web of Science ®Google Scholar
• Shieh L, Tamada J, Chen I, et al. Erosion of a new family of biodegradable polyanhydrides. J Biomed Mater Res 1994;28:1465-75
   PubMed Web of Science ®Google Scholar
• Yang XF, Zeng FD, Zhou ZB, et al. In vitro release and antibacterial activity of poly (oleic/linoleic acid dimer: sebacic acid)-gentamicin. Acta Pharmacol Sin 2003;24:306-10
   PubMed Web of Science ®Google Scholar
• Shikanov A, Domb AJ. Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer. Biomacromolecules 2006;7:288-96
   PubMed Web of Science ®Google Scholar
• Shikanov A, Domb AJ, Weiniger CF. Long acting local anesthetic–polymer formulation to prolong the effect of analgesia. J Control Release 2007;117:97-103
   PubMed Web of Science ®Google Scholar
• Shikanov A, Ezra A, Domb AJ. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel – effect of additives. J Control Release 2005;105:52-67
   PubMed Web of Science ®Google Scholar
• Slivniak R, Domb AJ. Macrolactones and polyesters from ricinoleic acid. Biomacromolecules 2005;6:1679-88
   PubMed Web of Science ®Google Scholar
• Cheng G, Aponte MA, Ramírez CA. Cross-linked amino acid-containing polyanhydrides for controlled drug release applications. Polymer 2004;45:3157-62
   Web of Science ®Google Scholar
• Uhrich KE, Larrier DR, Laurencin CT, et al. In vitro degradation characteristics of poly(anhydride-imides) containing pyromellitylimidoalanine. J Polym Sci A Polym Chem 1996;34:1261-9
   Web of Science ®Google Scholar
• Hamdan Y, Jiang X, Huang K, et al. Preparation and properties of copolyanhydrides based on 2-hexadecylsuccinic acid and sebacic acid. Am J Appl Sci 2007;4:128-32
   Google Scholar
• Korhonen H, Helminen AO, Seppälä JV. Synthesis of poly(ester-anhydrides) based on different polyester precursors. Macromol Chem Phys 2004;205:937-45
   Web of Science ®Google Scholar
• Cai QX, Zhu KJ, Chen D, et al. Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride–P(CBFAS). Eur J Pharm Biopharm 2003;55:203-8
   PubMed Web of Science ®Google Scholar
• Schmeltzer RC, Uhrich KE. Synthesis and characterization of salicylic acid-based poly(anhydride-ester) copolymers. J Bioact Compat Polym 2006;21:123-33
   PubMed Web of Science ®Google Scholar
• Silviniak R, Domb AJ. Stereocomplexes of enantiomeric lactic acid and sebacic acid ester-anhydride triblock copolymers. Biomacromolecules 2002;3:754-60
   PubMed Web of Science ®Google Scholar
• CBTRUS. Statistical report: primary brain tumors in the United States 1998 – 2002. Published by the Central Brain Tumor Registry of the United States; 2005
   Google Scholar
• Senior K. Glioblastoma: encouraging the body to fight back. Pharm Sci Technolo Today 2000;3:189-90
   PubMedGoogle Scholar
• Aoki T, Hashimoto N, Matsutani M. Management of glioblastoma. Expert Opin Pharmacother 2007;8:3133-46
   PubMed Web of Science ®Google Scholar
• Chang JE, Khuntia D, Robins HI, et al. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme. Clin Adv Hematol Oncol 2007;5:894-902, 907-15
   PubMedGoogle Scholar
• Mason WP. Emerging drugs for malignant glioma. Expert Opin Emerging Drugs 2008;13:81-94
   PubMed Web of Science ®Google Scholar
• Nicholas MK. Glioblastoma multiforme: evidence-based approach to therapy. Expert Rev Anticancer Ther 2007;7:S23-7
   Web of Science ®Google Scholar
• Barker FG 2nd, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42:709-20; discussion 720-3
   PubMed Web of Science ®Google Scholar
• Mohan DS, Suh JH, Phan JL, et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 1998;42:981-7
   PubMed Web of Science ®Google Scholar
• Domb A. Gliadel – a preparation for the supplementary treatment of brain cancer. Harefuah 1999;137:127-31
   PubMedGoogle Scholar
• Dang W, Daviau T, Ying P, et al. Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU. J Control Release 1996;42:83-92
   Web of Science ®Google Scholar
• Domb AJ, Israel ZH, Elmalak O, et al. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors. Pharm Res 1999;16:762-5
   PubMed Web of Science ®Google Scholar
• Brem H, Mahaley MS Jr, Vick NA, et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 1991;74:441-6
   PubMed Web of Science ®Google Scholar
• Grossman SA, Reinhard C, Colvin OM, et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J Neurosurg 1992;76:640-7
   PubMed Web of Science ®Google Scholar
• Fung LK, Ewend MG, Sills A, et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res 1998;58:672-84
   PubMed Web of Science ®Google Scholar
• Tamargo RJ, Myseros JS, Epstein JI, et al. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res 1993;53:329-33
   PubMed Web of Science ®Google Scholar
• Buahin KG, Brem H. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. J Neurooncol 1995;26:103-10
   PubMed Web of Science ®Google Scholar
• Sipos EP, Tyler B, Piantadosi S, et al. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol 1997;39:383-9
   PubMed Web of Science ®Google Scholar
• Ewend MG, Sampath P, Williams JA, et al. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. Neurosurgery 1998;43:1185-93
   PubMed Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 1995;345:1008-12
   PubMed Web of Science ®Google Scholar
• Westphal M, Ram Z, Riddle V, et al. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 2006;148:269-75
   PubMed Web of Science ®Google Scholar
• Valtonen S, Timonen U, Toivanen P, et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997;41:44-8
   PubMed Web of Science ®Google Scholar
• Westphal M, Hilt DC, Bortey E, et al. A phase III trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncol 2003;5:79-88
   PubMed Web of Science ®Google Scholar
• Li LC, Deng J, Stephens D. Polyanhydride implant for antibiotic delivery – from the bench to the clinic. Adv Drug Deliv Rev 2002;54:963-86
   PubMed Web of Science ®Google Scholar
• Stephens D, Li L, Robinson D, et al. Investigation of the in vitro release of gentamicin from a polyanhydride matrix. J Control Release 2000;63:305-17
   PubMed Web of Science ®Google Scholar
• Park E-S, Maniar M, Shah J. Effects of model compounds with varying physicochemical properties on erosion of polyanhydride devices. J Control Release 1996;40:111-21
   Web of Science ®Google Scholar
• Park E-S, Maniar M, Shah JC. Influence of physicochemical properties of model compounds on their release from biodegradable polyanhydride devices. J Control Release 1997;48:67-78
   Web of Science ®Google Scholar
• Deng JS, Li L, Tian Y, et al. The relationship between structures and in vitro properties of a polyanhydride implant containing gentamicin sulfate. Pharm Dev Technol 2001;6:541-9
   PubMed Web of Science ®Google Scholar
• Gopferich A, Schedl L, Langer R. The precipitation of monomers during the erosion of a class of polyanhydrides. Polymer 1996;37:3861-9
   Web of Science ®Google Scholar
• Jain JP, Modi S, Domb AJ, et al. Role of polyanhydrides as localized drug carriers. J Control Release 2005;103:541-63
   PubMed Web of Science ®Google Scholar
• Jain JP, Sokolsky M, Kumar N, et al. Fatty acid based biodegradable polymer. Polym Rev 2008;48:156-91
   Web of Science ®Google Scholar
• Katti DS, Lakshmi S, Langer R, et al. Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 2002;54:933-61
   PubMed Web of Science ®Google Scholar
• Domb AJ. Biodegradable polymers derived from amino acids. Biomaterials 1990;11:686-9
   Google Scholar
• Uhrich KE, Thomas TT, Laurencin CT, et al. In vitro degradation characteristics of poly(anhydride-imides) containing trimellitylimidoglycine. J Appl Polym Sci 1997;63:1401-11
   Web of Science ®Google Scholar
• Anseth KS, Shastri VR, Langer R. Photopolymerizable degradable polyanhydrides with osteocompatibility. Nat Biotechnol 1999;17:156-9
   PubMed Web of Science ®Google Scholar
• Poshusta AK, Burdick JA, Mortisen DJ, et al. Histocompatibility of photocrosslinked polyanhydrides: a novel in situ forming orthopaedic biomaterial. J Biomed Mater Res 2003;64A:62-9
   Web of Science ®Google Scholar
• Young JS, Gonzales KD, Anseth KS. Photopolymers in orthopedics: characterization of novel crosslinked polanhydrides. Biomaterials 2000;21:1181-8
   PubMed Web of Science ®Google Scholar
• Shastri VP, Padera RF, Tarcha P, et al. A preliminary report on the biocompatibility of photopolymerizable semi-interpenetrating anhydride networks. Biomaterials 2004;25:715-21
   PubMed Web of Science ®Google Scholar
• Weiner AA, Bock EA, Gipson ME, et al. Photocrosslinked anhydride systems for long-term protein release. Biomaterials 2008;29:2400-7
   PubMed Web of Science ®Google Scholar
• Mader K, Cremmilleux Y, Domb AJ, et al. In vitro/in vivo comparison of drug release and polymer erosion from biodegradable P(FAD-SA) polyanhydrides – a noninvasive approach by the combined use of electron paramagnetic resonance spectroscopy and nuclear magnetic resonance imaging. Pharm Res 1997;14:820-6
   PubMed Web of Science ®Google Scholar
• Krasko MY, Shikanov A, Ezra A, et al. Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid). J Polym Sci A Polym Chem 2003;41:1059-69
   Web of Science ®Google Scholar
• Schmeltzer RC, Anastasiou TJ, Uhrich KE. Optimized synthesis of salicylate-based poly(anhydride-esters). Polym Bull 2003;49:441-8
   Web of Science ®Google Scholar
• Choe YH, Kanamathareddy S, Goodrich S, et al. Improved and mild polymerization method for facile structural modification for biodegradable polymer drugs. PMSE Preprints 2005;92:92
   Google Scholar
• Schmeltzer RC, Schmalenberg KE, Uhrich KE. Synthesis and cytotoxicity of salicylate-based poly(anhydride esters). Biomacromolecules 2005;6:359-67
   PubMed Web of Science ®Google Scholar
• Cai Q, Zhu KJ, Zhang J. Salicylic acid and PEG-contained polyanhydrides: synthesis, characterization, and in vitro salicylic acid release. Drug Deliv 2005;12:97-102
   PubMed Web of Science ®Google Scholar
• Harten RD, Svach DJ, Schmeltzer R, et al. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo. J Biomed Mater Res A 2005;72:354-62
   PubMedGoogle Scholar
• Whitaker-Brothers K, Uhrich K. Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters). J Biomed Mater Res A 2006;76:470-9
   PubMed Web of Science ®Google Scholar
• Bryers JD, Jarvis RA, Lebo J, et al. Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo. Biomaterials 2006;27:5039-48
   PubMed Web of Science ®Google Scholar
• Korhonen H, Hakala RA, Helminen AO, et al. Synthesis and hydrolysis behaviour of poly(ester anhydrides) from polylactone precursors containing alkenyl moieties. Macromol Biosci 2006;6:496-505
   PubMed Web of Science ®Google Scholar
• Wiggins JS, Storey RF. Synthesis and characterization of rapidly biodegrading poly(d,l-lactide-co-glycolide) anhydrides. Polym Prepr 2005;46:333-4
   Google Scholar
• Jiang H, Chen D, Zhao P, et al. Novel copolyanhydrides combining strong inherent fluorescence and a wide range of biodegradability: synthesis, characterization and in vitro degradation. Macromol Biosci 2005;5:753-9
   PubMed Web of Science ®Google Scholar